Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.

× No keyword cloud information.

41 in total

1. Emerging clinical trends and perspectives on comorbid patterns of mental disorders in research.

Authors: Giovanni A Fava; Eliana Tossani; Per Bech; Carmen Berrocal; Guy Chouinard; Claudio Csillag; Hans-Ulrich Wittchen; Winfried Rief
Journal: Int J Methods Psychiatr Res Date: 2014-01 Impact factor: 4.035

Review 2. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors: Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal: CNS Drugs Date: 2013-07 Impact factor: 5.749

3. Aripiprazole withdrawal: a case report.

Authors: Randy A Sansone; Robert J Sawyer
Journal: Innov Clin Neurosci Date: 2013-05

4. Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients.

Authors: Paul Fallon; Serdar Dursun; Bill Deakin
Journal: Ther Adv Psychopharmacol Date: 2012-02

5. Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors: Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2019-08-19 Impact factor: 5.270

6. Powerful choices: peer support and individualized medication self-determination.

Authors: Corinna West
Journal: Schizophr Bull Date: 2009-06-10 Impact factor: 9.306

Review 7. Is schizophrenia a dopamine supersensitivity psychotic reaction?

Authors: Mary V Seeman; Philip Seeman
Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2013-10-12 Impact factor: 5.067

Review 8. New modalities of assessment and treatment planning in depression: the sequential approach.

Authors: Giovanni A Fava; Elena Tomba
Journal: CNS Drugs Date: 2010-06 Impact factor: 5.749

9. State-dependent effects of the D₂ partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia.

Authors: Susan F Sonnenschein; Kathryn M Gill; Anthony A Grace
Journal: Neuropsychopharmacology Date: 2018-09-18 Impact factor: 7.853

10. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.

Authors: Kathryn M Gill; James M Cook; Michael M Poe; Anthony A Grace
Journal: Schizophr Bull Date: 2014-01-24 Impact factor: 9.306